Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed)

US · MD National Institutes of Health (NIH) grant open #PAS-25-205

Response due Jan 06, 2028 · 00:00 UTC

Summary

The NIH National Institutes of Health is soliciting R01 research grant applications under the SHINE program to stimulate new hematology investigations. Clinical trials are explicitly not allowed under this funding opportunity. The program aims to encourage novel scientific endeavors in the field of hematology. The opportunity opened in November 2024 and accepts applications through January 2028, indicating a multi-cycle, standing program announcement.

What they want

Technical requirements

Research must fall within the domain of hematology
Clinical trials are explicitly not allowed
Must conform to NIH R01 grant application requirements

How they evaluate

Submission: Grants.gov federal portal (electronic submission per NIH R01 application instructions)

Risks & flags

No dollar value or award ceiling stated — budget constraints unknown
No specific evaluation criteria disclosed in the synopsis
Very broad multi-year open window (2024–2028) with minimal detail; full Program Announcement (PAS-25-205) must be reviewed for complete requirements

Market context

inferred from NAICS

Professional, Scientific & Technical Services

NAICS 541714

US market size: $2.0T
Typical award: $25K – $50M

Typical buyers

All federal civilianDoDStates

Commonly required

8(a)WOSBSDVOSBPE/PMP

Sector-level estimate — full code lookup not yet in catalog.

Stimulating Hematology Investigation: New …

Due Jan 06

Onboard ↗